MedTrace Logo

Gadolinium Retention in Human Bone Tissue in Pediatric Patients

NCT03337594 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2024-12-12

No results posted yet for this study

Summary

The purpose of this study is to compare contrast agents, Dotarem or MultiHance. The study will test to see how much of these two contrast agents are deposited in the bones or tissues of pediatric patients. The patients receiving contrast will then be compared against pediatric patients who have not received any contrast prior to cardiac surgeries.

Conditions

  • Gadolinium
  • MultiHance
  • Dotarem
  • Magnetic Resonance Imaging
  • Gadolinium Retention

Interventions

DRUG

Pre-operative MRI with Dotarem

Dotarem® (gadoterate meglumine - Guerbet)

DRUG

Pre-operative MRI with MultiHance

MultiHance® (gadobenate dimeglumine - Bracco)

PROCEDURE

Surgery

Cardiac surgery

Sponsors & Collaborators

  • National Institute of Standards and Technology

    collaborator UNKNOWN

  • Donna Roberts

    lead OTHER

Principal Investigators

  • Donna R Roberts, M.D. · Medical University of South Carolina

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2024-08-31
Completion
2024-08-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03337594 on ClinicalTrials.gov